產(chǎn)品詳情
簡單介紹:
A-431nuclearextract(EGFtreated)
詳情介紹:
Characteristics |
Origin: Human Epidermoid Carcinoma |
Components | 200 μg of A-431 nuclear extract (EGF treated) at 2.5 μg/μl |
Restrictions | For Research Use only |
Concentration | 2.5 μg/μL |
Buffer | Nuclear extracts are supplied in dilution buffer (20?mM Hepes (?pH 7.9), 100 mM KCl, 1?mM MgCl2, 20?% glycerol, 0.5 mM PMSF and 0.5 mM DTT). Cells were cultured in medium supplemented with 10?ng/mL EGF (epidermal growth factor) for 10?minutes at 37?°C immediately prior to harvesting. |
Preservative | Dithiothreitol (DTT) |
Precaution of Use | This product contains Dithiothreitol (DTT): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Handling Advice | It ist recommended to aliquot the extracts into single-use fractions and then storing them at -80 °C. This eliminates repeated freeze/thaw cycles. |
Storage | -80 °C |
Storage Comment | To ensure stability, extracts should be stored at -80°C. |